HIV molecular immunology database
Found 4 matching records:
HXB2 Location | Gag(147-155) | Gag Epitope Map
View variants at this location |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
ISPRTLNAW
|
Epitope Alignment | ||||||||||||||||||||||||||||
Variants |
|
|||||||||||||||||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 9 variant(s).
Variant ID. | 1280 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | lSPRTLNAW |
Mutations | I/L |
Epitope Location | I1L |
HXB2 Location | I147L |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 6/10 nonprogressors, 11/12 untreated progressors and 3/5 treated progressors. |
Variant ID. | 1281 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | ISaRTLNAW |
Mutations | P/A |
Epitope Location | P3A |
HXB2 Location | P149A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/5 treated progressors. |
Variant ID. | 1282 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | ISPRTLNAx |
Mutations | W/X |
Epitope Location | W9X |
HXB2 Location | W155X |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/10 nonprogressors. |
Variant ID. | 1283 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | ISPkTLNAW |
Mutations | R/K |
Epitope Location | R4K |
HXB2 Location | R150K |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/10 nonprogressors. |
Variant ID. | 1284 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | IaPRTLNAW |
Mutations | S/A |
Epitope Location | S2A |
HXB2 Location | S148A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/12 untreated progressors. |
Variant ID. | 1285 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | mSPRTLNAW |
Mutations | I/M |
Epitope Location | I1M |
HXB2 Location | I147M |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/12 untreated progressors. |
Variant ID. | 1286 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | mSaRTLNAW |
Mutations | I/M P/A |
Epitope Location | I1M P3A |
HXB2 Location | I147M P149A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/12 untreated progressors. |
Variant ID. | 1287 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | kSaRTLNAW |
Mutations | I/K P/A |
Epitope Location | I1K P3A |
HXB2 Location | I147K P149A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/12 untreated progressors. |
Variant ID. | 1288 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | lSPRTfNAW |
Mutations | I/L L/F |
Epitope Location | I1L L6F |
HXB2 Location | I147L L152F |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen in 1/12 untreated progressors. |
Migueles2003 Stephen A. Migueles, Alisha C. Laborico, Hiromi Imamichi, W. Lesley Shupert, Cassandra Royce, Mary McLaughlin, Linda Ehler, Julia Metcalf, Shuying Liu, Claire W. Hallahan, and Mark Connors. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors to Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences. J. Virol., 77(12):6889-6898, Jun 2003. PubMed ID: 12768008. Show all entries for this paper.
HXB2 Location | Gag(162-172) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
KAFSPEVIPMF
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | KAF11 | ||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 2 variant(s).
Variant ID. | 1289 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KsFSPEVIPMF |
Mutations | A/S |
Epitope Location | A2S |
HXB2 Location | A163S |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen only in one non-progressor and one treated progressor. Index epitope KAF11 is immunodominant in several subjects and highly conserved. |
Variant ID. | 1290 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KgFnPEVIPMF |
Mutations | A/G S/N |
Epitope Location | A2G S4N |
HXB2 Location | A163G S165N |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant was seen only in one untreated progressor. |
Migueles2003 Stephen A. Migueles, Alisha C. Laborico, Hiromi Imamichi, W. Lesley Shupert, Cassandra Royce, Mary McLaughlin, Linda Ehler, Julia Metcalf, Shuying Liu, Claire W. Hallahan, and Mark Connors. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors to Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences. J. Virol., 77(12):6889-6898, Jun 2003. PubMed ID: 12768008. Show all entries for this paper.
HXB2 Location | Gag(240-249) | Gag Epitope Map
View variants at this location |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
TSTLQEQIGN
|
Epitope Alignment | ||||||||||||||||
Variants |
|
|||||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 5 variant(s).
Variant ID. | 1291 |
---|---|
Epitope Seq. | TSTLQEQIGN |
Variant Seq. | TSnLQEQIGN |
Mutations | T/N |
Epitope Location | T3N |
HXB2 Location | T242N |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is seen in 4/10 nonprogressors, 4/12 untreated progressors and 3/5 treated progressors. |
Variant ID. | 1292 |
---|---|
Epitope Seq. | TSTLQEQIGN |
Variant Seq. | TtnLQEQIaN |
Mutations | S/T T/N G/A |
Epitope Location | S2T T3N G9A |
HXB2 Location | S241T T242N G248A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is seen in 1/12 untreated progressors. |
Variant ID. | 1293 |
---|---|
Epitope Seq. | TSTLQEQIGN |
Variant Seq. | TSnLQEQIaN |
Mutations | T/N G/A |
Epitope Location | T3N G9A |
HXB2 Location | T242N G248A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is seen in 2/10 nonprogressors, 5/12 untreated progressors and 2/5 treated progressors. |
Variant ID. | 1294 |
---|---|
Epitope Seq. | TSTLQEQIGN |
Variant Seq. | TSnLQEQvaN |
Mutations | T/N I/V G/A |
Epitope Location | T3N I8V G9A |
HXB2 Location | T242N I247V G248A |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is seen in 1/12 untreated progressor. |
Variant ID. | 1295 |
---|---|
Epitope Seq. | TSTLQEQIGN |
Variant Seq. | TSnLQEQIqN |
Mutations | T/N G/Q |
Epitope Location | T3N G9Q |
HXB2 Location | T242N G248Q |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is seen in 1/12 untreated progressor. |
Migueles2003 Stephen A. Migueles, Alisha C. Laborico, Hiromi Imamichi, W. Lesley Shupert, Cassandra Royce, Mary McLaughlin, Linda Ehler, Julia Metcalf, Shuying Liu, Claire W. Hallahan, and Mark Connors. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors to Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences. J. Virol., 77(12):6889-6898, Jun 2003. PubMed ID: 12768008. Show all entries for this paper.
HXB2 Location | Gag(308-316) | Gag Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
QASQEVKNW
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Epitope Name | QW9 | ||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 4 variant(s).
Variant ID. | 1296 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QASQdVKNW |
Mutations | E/D |
Epitope Location | E5D |
HXB2 Location | E312D |
Mutation Type | NSF: non-susceptible form SF: susceptible form |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | The E312D variant is more common in progressors (8/17) than controllers (1/10) of infection. This variant does not reliably confer loss of binding to HLA. 2/4 carriers of this variant and not the consensus, recognized it, but 2/4 did not. |
Variant ID. | 1297 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QAtQEVKNW |
Mutations | S/T |
Epitope Location | S3T |
HXB2 Location | S310T |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is found in 1/10 nonprogressors and 1/12 untreated progressors. |
Variant ID. | 1298 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QAtQdVKNW |
Mutations | S/T E/D |
Epitope Location | S3T E5D |
HXB2 Location | S310T E312D |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is found in 1/10 nonprogressors. |
Variant ID. | 1299 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QASQdVKNx |
Mutations | E/D W/X |
Epitope Location | E5D W9X |
HXB2 Location | E312D W316X |
Mutation Type | OV: observed variant |
Method | Sequence |
Note | This variant is found in 1/10 nonprogressors. |
Migueles2003 Stephen A. Migueles, Alisha C. Laborico, Hiromi Imamichi, W. Lesley Shupert, Cassandra Royce, Mary McLaughlin, Linda Ehler, Julia Metcalf, Shuying Liu, Claire W. Hallahan, and Mark Connors. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors to Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences. J. Virol., 77(12):6889-6898, Jun 2003. PubMed ID: 12768008. Show all entries for this paper.